Published data has been demonstrated that IL-37 can alleviate the symptoms of DSS colitis and inflammatory process in psoriasis by inhibiting the expression of inflammatory cytokines in these diseases [28], [31] and reduce liver inflammatory injury via effects on hepatocytes and non-parenchymal cells [29]. This evidence concerns the gene IL37 and psoriasis.